Lupron Depot-Ped



Indications and Reactions:

Role Indications Reactions
Primary
Precocious Puberty 54.1%
Product Used For Unknown Indication 25.5%
Drug Use For Unknown Indication 5.8%
Attention Deficit/hyperactivity Disorder 2.0%
Seasonal Allergy 1.6%
Vitamin Supplementation 1.6%
Epilepsy 1.3%
Headache 1.1%
Hypersensitivity 1.1%
Hormone Level Abnormal 0.9%
Endometriosis 0.7%
Gastrooesophageal Reflux Disease 0.7%
Juvenile Idiopathic Arthritis 0.7%
Anxiety 0.4%
Asthma 0.4%
Blood Growth Hormone 0.4%
Complex Partial Seizures 0.4%
Convulsion 0.4%
Depression 0.4%
Hypertension 0.4%
Injection Site Pain 9.9%
Incorrect Dose Administered 9.2%
Drug Dispensing Error 8.5%
Weight Increased 7.7%
Pyrexia 6.3%
Injection Site Abscess 5.6%
Injection Site Swelling 5.6%
Convulsion 4.9%
Drug Dose Omission 4.9%
Headache 4.2%
Drug Ineffective 3.5%
Injection Site Abscess Sterile 3.5%
Injection Site Reaction 3.5%
Mood Swings 3.5%
Rash 3.5%
Urticaria 3.5%
Wrong Drug Administered 3.5%
Abscess Sterile 2.8%
Hypertension 2.8%
Medication Error 2.8%
Secondary
Precocious Puberty 53.2%
Product Used For Unknown Indication 10.6%
Uterine Leiomyoma 6.4%
Drug Use For Unknown Indication 3.5%
Anaemia 2.8%
Headache 2.8%
Vitamin Supplementation 2.8%
Hypersensitivity 2.1%
Menorrhagia 2.1%
Attention Deficit/hyperactivity Disorder 1.4%
Endometriosis 1.4%
Gastrooesophageal Reflux Disease 1.4%
Hypertension 1.4%
Left Ventricular Hypertrophy 1.4%
Migraine Prophylaxis 1.4%
Thermal Burn 1.4%
Vaginal Haemorrhage 1.4%
Asthma 0.7%
Breast Enlargement 0.7%
Hypothyroidism 0.7%
Weight Increased 13.6%
Drug Dispensing Error 11.4%
Injection Site Pain 11.4%
Incorrect Dose Administered 6.8%
Drug Effect Decreased 4.5%
Hormone Level Abnormal 4.5%
Incorrect Drug Dosage Form Administered 4.5%
Menstrual Disorder 4.5%
Overdose 4.5%
Pharyngitis Streptococcal 4.5%
Precocious Puberty 4.5%
Rash Pruritic 4.5%
Wrong Drug Administered 4.5%
Arthralgia 2.3%
Bone Cyst 2.3%
Disease Recurrence 2.3%
Drug Ineffective 2.3%
Drug Level Changed 2.3%
Drug Name Confusion 2.3%
Dyspnoea 2.3%
Concomitant
Product Used For Unknown Indication 73.3%
Convulsion 13.3%
Growth Hormone Deficiency 6.7%
Metastases To Bone 6.7%
Convulsion 33.3%
Osteonecrosis Of Jaw 33.3%
Snoring 33.3%